Table 1.
Drug price change due to the “4 + 7” collective pharmaceutical procurement and associated providers.
| No. | Drug | Format | Price before 4 + 7 (CNY, USD) * | 4 + 7 contract price, (CNY, USD)† | Price change | Contractor‡ | Market share§, % | Market share rank‖ |
|---|---|---|---|---|---|---|---|---|
| 1 |
Atorvastatin |
Tablet |
¥5.00, $0.76 |
¥0.94, $0.14 |
-81.1% |
Jialin |
17.42 |
2 |
| 2 |
Rosuvastatin |
Tablet |
¥5.98, $0.90 |
¥0.78, $0.12 |
-87.0% |
Jingxin |
6.91 |
3 |
| 3 |
Clopidogrel |
Tablet |
¥3.68, $0.56 |
¥3.18, $0.48 |
-13.6% |
Salubris |
30.13 |
2 |
| 4 |
Irbesartan |
Tablet |
¥3.04, $0.46 |
¥0.20, $0.03 |
-93.4% |
Huahai |
0.61 |
11 |
| 5 |
Amlodipine |
Tablet |
¥1.88, $0.28 |
¥0.15, $0.02 |
-92.1% |
Jingxin |
0.02 |
23 |
| 6 |
Entecavir |
Tablet |
¥28.06, $4.24 |
¥0.62, $0.09 |
-97.8% |
Chia Tai-Tianqing |
44.22 |
1 |
| 7 |
Escitalopram |
Tablet |
¥13.94, $2.11 |
¥4.42, $0.67 |
-68.3% |
KELUN |
9.93 |
3 |
| 8 |
Paroxetine |
Tablet |
¥4.26, $0.64 |
¥1.67, $0.25 |
-60.8% |
Huahai |
41.47 |
2 |
| 9 |
Olanzapine |
Tablet |
¥24.03, $3.63 |
¥9.64, $1.46 |
-59.9% |
Hansoh |
59.99 |
1 |
| 10 |
Cefuroxime |
Tablet |
¥0.60, $0.09 |
¥0.51, $0.08 |
-14.2% |
Beite |
2.63 |
7 |
| 11 |
Risperidone |
Tablet |
¥3.24, $0.49 |
¥0.17, $0.03 |
-94.8% |
Huahai |
5.73 |
6 |
| 12 |
Gefitinib |
Tablet |
¥63.00, $9.52 |
¥54.70, $8.26 |
-13.2% |
Qilu Hainan |
11.45 |
2 |
| 13 |
Fosinopril |
Tablet |
¥2.80, $0.42 |
¥0.84, $0.13 |
-69.9% |
Squibb |
82.81 |
1 |
| 14 |
Irbesartan/Hydrochlorothiazide |
Tablet |
¥4.40, $0.66 |
¥1.09, $0.16 |
-75.2% |
Huahai |
4.72 |
4 |
| 15 |
Lisinopril |
Tablet |
¥0.26, $0.04 |
¥0.23, $0.03 |
-11.6% |
Huahai |
35.68 |
1 |
| 16 |
Tenofovir |
Tablet |
¥6.67, $1.01 |
¥0.59, $0.09 |
-91.1% |
Beite |
4.02 |
3 |
| 17 |
Losartan |
Tablet |
¥5.60, $0.85 |
¥1.05, $0.16 |
-81.3% |
Huahai |
6.57 |
3 |
| 18 |
Enalapril |
Tablet |
¥0.22, $0.03 |
¥0.56, $0.08 |
150.4% |
Yangzijiang |
76.58 |
1 |
| 19 |
Levetiracetam |
Tablet |
¥3.78, $0.57 |
¥2.40, $0.36 |
-36.5% |
Jingxin |
0.43 |
3 |
| 20 |
Imatinib |
Tablet |
¥45.00, $6.80 |
¥10.40, $1.57 |
-76.9% |
Hansoh |
12.35 |
2 |
| 21 |
Montelukast |
Tablet |
¥6.40, $0.97 |
¥3.88, $0.59 |
-39.4% |
Minsheng |
2.71 |
4 |
| 22 |
Montmorillonite |
Granule |
¥1.84, $0.28 |
¥0.68, $0.10 |
-63.1% |
Simcere |
3.71 |
3 |
| 23 |
Pemetrexed |
Injection |
¥1160.20, $175.26 |
¥2776.97, $419.48 |
139.4% |
Huiyu |
4.28 |
4 |
| 24 | Flurbiprofen | Injection | ¥12.82, $1.94 | ¥21.95, $3.32 | 71.3% | Tide | 98.33 | 1 |
*CNY, Chinese Yuan (¥). USD, US Dollar ($). Composite price per unit before “4 + 7” procurement, converted to 2018 CNY and USD according to currency exchange rate and consumer price index (CPI).
†Composite price per unit in “4 + 7” contract, converted to 2018 CNY and USD according to currency exchange rate and CPI.
‡Beite, Chengdu Beite Pharmaceutical Industry. Chia Tai-Tianqing, Chia Tai-Tianqing Pharmaceutical Holdings Co., Ltd Hansoh, Jiangsu Hansoh pharmaceuticals. Huahai, Zhejiang Huahai Pharmaceutical Co., Ltd Huiyu, Sichuan Huiyu Pharmaceutical Limited. Jialin, Beijing Jialin Pharmaceutical Industry Company Limited. Jingxin, Zhejiang Jingxin Pharmaceutical Co. Ltd KELUN, Sichuan KELUN PHARMACEUTICAL Co., Ltd Minsheng, Hangzhou Minsheng Binjiang Pharmaceuticals. Qilu Hainan, Qilu Pharmaceutical Hainan Co., Ltd Salubris, Shenzhen Salubris Pharmaceuticals. Simcere, Hainan Simcere Pharmaceuticals. Squibb, Sino-American Shanghai Squibb Pharmaceuticals Ltd Tide, Beijing Tide Pharmaceutical Co., Ltd Yangzijiang, Yangzijiang Pharmaceuticals.
§Market share, sales volume proportion of contractor in the separate drug market.
‖Market share rank, the rank of sales volume of contractor in the separate drug market.